Research Faculty & Staff

Medical physicist Andrew Jackson studies the relationship between radiotherapy dose distributions and treatment outcome and the optimization of radiotherapy treatment planning.

Our research group uses a combination of preclinical, translational and clinical trial investigations to identify strategies that lead to the most favorable breast cancer outcomes, ie maximizing the chances of disease control while minimizing toxicities.

Physician-scientist Daniel Higginson studies a double-strand break repair pathway known as microhomology-mediated end joining, with the overall goal of improving the understanding of radiation treatment and providing insight into therapies for cancers deficient in homologous recombination.

The Shouval Lab focuses on improving the safety and effectiveness of cellular therapies by unraveling and mitigating resistance and toxicity mechanisms using multiomic and computational strategies.

Medical physicist Sunitha Thakur focuses on MR biomarkers for early detection and monitoring response to treatment.

Digital pathology scientist Yukako Yagi, PhD studies the development and validation of technologies in digital imaging.